Noida, UP -- (SBWire) -- 12/11/2014 --According to a new research report by RNCOS, titled "Global Insulin Delivery Devices Market Outlook 2018", the discovery of Artificial pancreas has been described as the next revolution in Diabetes Care. The artificial pancreas substitutes the endocrine functions of a healthy pancreas and automatically controls the blood glucose levels in diabetic patients. An artificial pancreas is used in the form of medical equipment comprising of an insulin pump under closed loop control, and a blood glucose sensor. The sensor continuously monitors blood glucose and sends the information to the insulin pump. The pump then supplies the right amount of hormone in the body if needed. The University of Cambridge recently conducted studies in 100 diabetic patients with artificial pancreas. The therapy proved to be effective in lowering the blood glucose levels. Moreover, scientists at the Juvenile Diabetes Research Foundation in the US have been working to develop artificial pancreatic systems that may dose insulin automatically without the need of a painful finger pricking procedure. The technique will benefit patients with type 1 diabetes.
The report is spread in over 115 pages and provides an in-depth research and rational analysis of the current status and future prospect of the insulin delivery systems market. The study presents a global picture about the prevalence of diabetes and the overall market for insulin delivery systems. It includes a geographical analysis of insulin delivery systems in key diabetic countries. The research further covers the market for main insulin delivery systems along with their current and future projections. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche, and Becton Dickenson and Company, which together account for more than 90% of the global market.
For FREE SAMPLE of this report visit:
http://www.rncos.com/Report/IM723.htm
Check Related REPORTS on:
http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
Artificial Pancreas - "Next Innovation" in Diabetes Care
The rising popularity of Artificial Pancreas driving the Insulin Delivery Device Market, Says RNCOS.